Bio-Techne/TECH

$62.73

-1.99%
-
1D1W1MYTD1YMAX

About Bio-Techne

Bio-Techne Corporation is a global life sciences company. The Company is engaged in providing tools and bioactive reagents for the research and clinical diagnostic communities. It operates through two segments: Protein Sciences and Diagnostics and Genomics. Its Protein Sciences segment develops and manufactures biological reagents used in all aspects of life science research, diagnostics and cell and gene therapy. This segment also includes proteomic analytical tools, both manual and automated, that offer researchers and pharmaceutical manufacturers efficient and streamlined options for automated western blot and multiplexed ELISA workflow. The Diagnostics and Genomics segment develops and manufactures diagnostic products, including controls, calibrators, and diagnostic assays for the regulated diagnostics market, exosome-based molecular diagnostic assays, advanced tissue-based in-situ hybridization assays for spatial genomic and tissue biopsy analysis, and genetic and oncology kits.

Ticker

TECH

Sector

Healthcare

Trading on

NASDAQ

Industry

Biotechnology & Drugs

CEO

Kim Kelderman

Employees

3,050

Headquarters

Minneapolis, United States

Bio-Techne Metrics

BasicAdvanced
$10.3B
Market cap
47.26
P/E ratio
$1.39
EPS
1.22
Beta
$0.32
Dividend rate
0.49%
Dividend yield
$10.3B
1.22228
$89.91
$51.79
1.08M
$0.32
4.368
3.03
22.765
22.765
22.48%
45.545
18.86%
8.8%
11.82%
9.28%
47.263
8.995
5.244
23.793
58.853
0.4%
0.49%
0.49%
2.25%
-13.76%
15.45%
6.63%

What the Analysts think about Bio-Techne

Analyst Ratings

Majority rating from 13 analysts.
Buy

Price Targets

Average projection from 11 analysts.
28.84% upside
High $95.00
Low $65.00
$62.73
Current price
$80.82
Average price target

Bio-Techne Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
10.05% profit margin
QuarterlyAnnual
Q2 24
QoQ growth
Revenue
$272.5M
-1.59%
Net income
$27.4M
-46.17%
Profit margin
10.05%
-45.32%

Bio-Techne Earnings Performance

Earnings per share (EPS)

Company profitability
Missed by 3.05%
QuarterlyAnnual
Q3 23
Q4 23
Q1 24
Q2 24
Q3 24
Actual
$0.53
$0.55
$0.41
$0.40
-
Expected
$0.53
$0.55
$0.44
$0.41
$0.45
Surprise
0.36%
0.58%
-5.8%
-3.05%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. Fundamental data, financials and analyst ratings are sourced from Refinitiv.

Upcoming events

FAQs

What’s the current market cap for Bio-Techne stock?

Bio-Techne (TECH) has a market cap of $10.3B as of April 17, 2024.

What is the P/E ratio for Bio-Techne stock?

The price to earnings (P/E) ratio for Bio-Techne (TECH) stock is 47.26 as of April 17, 2024.

Does Bio-Techne stock pay dividends?

Yes, the Bio-Techne (TECH) stock pays dividends to shareholders. As of April 17, 2024, the dividend rate is $0.32 and the yield is 0.49%. Bio-Techne has a payout ratio of 22.48% on a trailing twelve-month basis.

When is the next Bio-Techne dividend payment date?

The next Bio-Techne (TECH) dividend payment date is unconfirmed.

What is the beta indicator for Bio-Techne?

Bio-Techne (TECH) has a beta rating of 1.22. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.

What is the Bio-Techne stock price target?

The target price for Bio-Techne (TECH) stock is $80.82, which is 28.84% above the current price of $62.73. This is an average based on projections from 11 analysts, and represents their view of what the stock price could be in 12 or 18 months. This should not be seen as investment advice - Lightyear does not carry out investment research.

Buy or sell Bio-Techne stock

Buy or sell Bio-Techne stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing